Pipeline

Program
PDC
discovery
Lead Optimization
IND Enabling
Phase I
Phase II
Acidity-PET Imaging
pHLIP® PET for imaging primary tumors and metastases
Fluorescence-Guided Surgery
pHLIP® ICG for imaging tumors and vasculature
Immuno-Oncology
pHLIP® Antigen for treatment of primary tumors and metastases
Immuno-Oncology
pHLIP® Immuno-modulators for reduction of immuno-suppression

PDC: pHLIP® Drug Conjugate

Other PDCs are being developed by Sublicensees or in collaboration with Pharma

Our goal is to establish PDCs as a standard of care for targeted therapeutics